James Patrick Tursi, Chief Medical Officer at Aralez Pharmaceuticals Inc. (ARLZ), bought 4,750 shares at $2.11 ($10K) on 2017-03-15, disclosed to the SEC on 2017-03-17.
Open-market purchase of $10k ARLZ by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ARLZ | SELL | 2017-10-04 | $25K | — | Filing → |
| ARLZ | BUY | 2016-05-23 | $38K | — | Filing → |
| ARLZ | BUY | 2016-05-18 | $17K | — | Filing → |